Impaired Cognitive Function: Clinical Trials

1 trial for Impaired Cognitive Function, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Impaired Cognitive Function: new trials by email Literature Review of Impaired Cognitive Function trials Research Report on Impaired Cognitive Function

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
Solriamfetol, Placebo - Excessive Daytime Sleepiness, Obstructive Sleep Apnea
Phase 4CompletedAxsome Therapeutics, Inc.592021-05-172026-01-26

Narrower conditions

Disorders of Excessive Somnolence (1)  ·  Sleep Apnea, Obstructive (1)

Broader conditions

Apnea (1)  ·  Dyssomnias (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Interventions

solriamfetol (1)

Sponsors

Axsome Therapeutics, Inc. (1)

Countries

Canada (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 39528111